CharlieAJA
- TransMedics (NASDAQ:TMDX) is ~6% larger in after-hours buying and selling Thursday after posting 2025 income steering above the consensus determine.
- The medtech sees income this 12 months of $530M-$552M. Consensus is $521.62M.
- In This fall, TransMedics (NASDAQ:TMDX) beat on each traces.
- Within the quarter, internet